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Sumlllary 
Inflammatory cytokines have been implicated in the pathogenesis of rheumatoid arthritis (RA), 
whereas the mechanisms for constitutive production of inflammatory cytokines in affected  joints 
are largely unknown. Recently, integrin-mediated interaction with extracellular matrix (ECM) 
proteins has been demonstrated to play a role in regulating cytokine production in T cells and 
monocytes. In this study, we investigated the contribution of the/31 integrin-mediated interaction 
with ECM proteins to the persistent cytokine gene expression in RA synovial fluid mononuclear 
cells (SFMNC). We examined mRNA expression of 14 cytokines in the SFMNC of three RA 
patients,  which were either fresh or cultured overnight in serum-free medium on ECM-coated 
plates, by polymerase chain reaction with a panel of oligonucleotide primers  specific for each 
cytokine.  The persistent  expression of various cytokine mRNA found in fresh SFMNC was 
maintained after overnight culture in serum-free medium on ECM proteins, especially on laminin 
(LM), but not on serum albumin. This effect of LM was inhibited by an anti-integrin/31 chain 
(CD29) mAb, as well as by an anti-CD3 mAb, indicating an important role of the/31 integrin- 
mediated interaction with ECM proteins  in regulating persistent  cytokine gene expression in 
RA SFMNC, and a key role of T  cells in regulating inflammatory monokine production. 
heumatoid arthritis (RA) is a chronic inflammatory dis- 
ease with autoimmune features that is characterized by 
erosive bone and cartilage degradation in synovial joints (1). 
Inflammatory cytokines, including II.-1, TNF, IFN-qr  GM- 
CSF, and IL-8, have been implicated in the pathogenesis  of 
RA (1, 2). These cytokines contribute to initiate  and am- 
plify the inflammation directly or indirectly by inducing the 
release of degrading enzymes and chemical mediators from 
synovial cells and infiltrating cells, or by recruiting and ac- 
tivating inflammatory cells. The presence of these cytokines 
has been demonstrated in situ or in the synovial fluid (SF) 
of RA patients  (2, 3),  and a spontaneous  release of these 
cytokines in cultures of RA synovial cells has been commonly 
observed (2, 4, 5). However, little is known about the cause 
of the persistent cytokine production in the affected joints. 
Chronic synovial inflammation in RA is characterized by 
marked infiltration  of mononuclear cells (MNC) into both 
the tissues and SF. In these infiltrates, activated T cells with 
increase expression of CD25, HLA-DR, and CD29 (/~1 inte- 
grins) are commonly observed (6-8). These T cells are thought 
to play a role in the initiation and perpetuation of the inflam- 
matory  reactions  within  the  affected joints  by  directly 
damaging the tissues or by indirectly regulating the inflam- 
matory cells by the cytokines they produce (1). At present, 
the antigen responsible for eliciting T cell-mediated immune 
responses within the RA joint has not yet been identified, 
although the involvement of some cartilage proteins or self 
stress proteins  has  been suggested  (9,  10). However,  ac- 
cumulating evidence indicates that the T cell activation re- 
quires not only the antigen stimulation, but also a costimula- 
tory signal mediated by some accessory molecules (11, 12). 
Recently,/31 integrin-mediated interaction with various 
extracellular matrix (ECM) proteins has been implicated in 
leukocyte migration and activation (13, 14). VLA-4- and VLA- 
5-mediated interaction with fibronectin  (FN),  and VLA- 
6-mediated interaction with laminin (LM) have been demon- 
strated  to deliver a costimulatory signal required  for II.-2 
production and proliferation of anti-CD3-stimulated periph- 
eral blood T cells. In our previous study, we demonstrated 
that the integrin-mediated interaction with ECM proteins 
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functions of murine T  cell lines,  such as degranulation and 
I1:2 production, in an antigen-independent manner (15). It 
has been documented that T cells with elevated 81 integrins 
were accumulated in the RA synovial compartment (7, 8), 
and that T cells from RA subjects were stimulated in response 
to ECM proteins (16, 17). Therefore, it seems likely that the 
stimulatory signal mediated by B1 integrins may play a role 
in regulating the effector functions of chronically activated 
T cells in RA synovium abundant in ECM proteins. In the 
present study, we describe  the involvement of 81 integrin- 
mediated interaction with ECM proteins in regulating var- 
ious cytokine gene expression  in SFMNC of RA patients, 
persistent production of which has been implicated in the 
pathogenesis of RA. 
Materiah  and Methods 
Study Subjects.  SF samples were obtained from three patients 
fulfilling the American Rheumatism Association criteria for the 
classification  of  RA (18) at therapeutic aspiration  from the inflamed 
knee  joints (see Table 1). The age range was from 42 to 61 yr. Dis- 
ease duration ranged from 2 to 33 yr. All the patients were RF 
positive  and  receiving nonsteroidal  antiinflammatory  drugs 
(NSAID). 
Preparation  and Culture of  SFMNC.  SFMNC  were prepared from 
SF treated with hyaluronidase (10 U/ml) for 30 min at 37~  by 
FicoU-Hypaque  density gradient centrifugation at 400 g for 40 min, 
washed three times, and resuspended  in serum-free  AIM-V medium 
(Gibco, Grand Island, NY).  SFMNC contained 19-70% CD3 + 
T cells, 35-81% of which were HLA-DR*, and 18-58% CD14 + 
monocytes as estimated by FACS  |  analysis (see Table 1). The re- 
mains were contaminated PMN,  as estimated by histochemical 
staining. SFMNC resuspended in AIM-V (5  x  106 ceUs/ml) were 
cultured in 24-well plates (Coming Inc., Corning,  NY), which 
were precoated with 10 #g/ml of human plasma FN (Gibco), bo- 
vine type II collagen (Koken, Tokyo, Japan), mouse LM (Sigma 
Immunochemicals,  St. Louis, MO), or BSA (Sigma Immunochem- 
icals), for 16 h at 37~  in the presence or absence of 10/~g/ml 
of an anti-CD29 (integrin 81 chain) mAb 4B4 (kindly provided 
by Dr. C. Morimoto, Dana-Farber Cancer Institute, Boston, MA), 
an anti-CD18 mAb TS1/18 (purchased from American Type Cul- 
ture Collection, Rockville, MD), an anti-CD44 mAb NIH44-1 
(kindly provided by Dr. S. Shaw, National Institutes of Health, 
Bethesda, MD), or Fab fragment of  an anti-CD3 mAb OKT-3 (pur- 
chased from the American Type  Culture Collection). The cultured 
cells were collected  by a brief treatment with 0.05% EI~A in PBS. 
PCR-assisted  Detection  of Cytokine mRNA.  Cytoplasmic RNA 
was prepared from fresh or cultured SFMNC by the NP-40 method 
(19). First-strand cDNA was synthesized  from 2/~g of RNA with 
0.5/xg of oligo(dT)  primer by using the SuperScript Preamplification 
System (GIBCO BILL,  Gaithersburg, MD) in 20/~1 of the reaction 
mixture. All the PCR primers specific  for IL-lc~, IL-1B, IL-2, Ib3, 
I1_,4, IL-5, IL-6, Ib7, IL-8, IFN-% TNF-o~, TNF-fl, TGF~fl,  GM- 
CSF, and B-actin were purchased from Clonotech (palo Alto, CA). 
For PCR, 0.1/~1 of cDNA was amplified  in the presence of I #M 
each of the 5' and 3' primers, 5/~M digoxigenin-ll-dUTP  (Boeh- 
ringer Mannheim, Tokyo,  Japan), 200/~M dNTPs, 0.5 U of Taq 
polymerase (Cetus Corp., Emeryville, CA), and PCR buffer con- 
taining 2.5 #M MgC12, 50 mM KC1, 10 mM Tris-HC1 (pH 8.3), 
and 0.001% gelatin in a final  volume of 20/~1. PCR was performed 
in a DNA thermal cycler (Cetus Corp.) for 30 cycles (94~  for 
1 rain, 60~  for 2 rain, and 72~  for 3 min) followed  by a 10-rain 
extension at 72~  8 #1 of the PCR products was subjected to 
electrophoresis on 2% agarose  gels, blotted onto nylon membrane 
(Biodyne; Pall, Glen Cove, NY), and detected by using an alkaline 
phosphatase-labeled antidigoxigenin antibody and a chemilumines- 
cent  substrate, AMPPD  (DIG  Luminescent  Detection  Kit; 
Boehringer  Mannheim),  according to  the  manufacturer's  in- 
structions. 
Results 
Expression  of various  cytokine genes  was  detected  in 
SFMNC freshly isolated from the three RA patients as esti- 
mated by the PCR detection method with a panel of oligo- 
nudeotide primers specific  for each cytokine (Fig. 1). Although 
some  individual differences  were  observed,  these  include 
inflammatory  monokines, such as IL-lc~, I1:1fl, 1I:8, TNF-o~, 
and lymphokines predominantly produced by T  cells, such 
as I1:2, IFN-% and GM-CSF. This is consistent with previous 
studies where the expression of these cytokine genes was as- 
sessed by Northern blotting or in situ hybridization (2). 
Table  1.  Characteristics  of the Studied Subjects 
Disease 
classification 
Duration 
Patient  Sex  Age  of disease  Class  Stage 
Phenotype of SFMNC 
RF  Medications  CD3 §  DR +/CD3 +  CD 14 + 
yr 
1  F  53  8  I*  III 
2  F  61  33  II  II 
3  F  42  2  II  II 
+ t  NSAIDS  70%1L  38%  18% 
+  NSAID  69%  81%  20% 
+  NSAID  19%  35%  58% 
* Steinbrocker's classification. 
Rheumatoid factors assessed by latex fixation test. 
S  Non steroidal antiinflammatory  drug. 
II Results of FACS  |  analysis. 
864  ~1 Integrin Regulates Cytokine Gene Expression in RA Figure  1.  Cytokine  gene expression in fresh SFMNC. Cytoplasmic 
RNA prepared from fresh SFMNC of three RA patients was subjected 
to PCtL detection of the indicated cytokine  mRNAs. 
Figure 2.  Cytokine  gene  expression  in SFMNC cultured  on ECM pro- 
teins. Cytoplasmic  RNA prepared  from SFMNC (patient 1), which  were 
cultured  for 16 h in serum-free  medium  on BSA-, FN-, LM-, or CL-coated 
plates, was subjected  to PCR detection  of  the indicated  cytokine  mRNAs. 
Such  an  apparently  spontaneous  expression  of various 
cytokine genes in SFMNC ceased after a brief culture in a 
serum-free medium on BSA-coated plates, although the tran- 
scription of/~-actin gene was not affected (Fig. 2). The latter 
indicates that the cessation of cytokine gene transcription was 
not due to reduced viability of SFMNC in the serum-free 
culture. In contrast, when SFMNC were cultured on LM- 
coated plates,  the transcriptional levels of IL-lot, IL-I/~, I1:2, 
IIr7, IFN-3', and TNF-ot were totally retained (Fig.  2). The 
transcription of IL-7 and IFN-3' genes was also retained on 
FN- or C1:coated plates albeit to a lesser extent. These results 
indicated that ECM proteins, especially LM,  affect the ex- 
pression of various cytokine genes including inflammatory 
cytokines such as I1:1c~, IL-13, I1:8,  IFN-%  and TNF-cr 
It has been known that/31  integrins, including VLA-1, 
VLA-2, VLA-3, and VLA-6, are primarily responsible for the 
interaction of leukocytes with LM (13).  In this respect, we 
examined whether the effect of LM to perpetuate cytokine 
gene expression in SFMNC is mediated by the 31 integrins 
by estimating the blocking by an anti-CD29  (integrin 31 
chain) mAb. As indicated in Fig.  3 A, the expression of I1: 
lot,  IL-13,  TNF-c~,  and IFN-3, genes, which was retained 
on LM but not on BSA, was greatly reduced by the addition 
of anti-CD29  mAb.  Such an inhibitory effect was not ob- 
served with anti-CD18 (Fig. 3 A) or anti-CD44 mAb (data 
not shown). Similar results were also obtained with cultures 
of SFMNC from the other two patients (Fig.  3, B and C). 
The reduction of I1:1 and TNF-ot gene transcription on LM 
was commonly observed in the presence of anti-CD29 mAb. 
It should be noted that the expression of cytokines that are 
predominantly produced by T cells, including I1:2, I1:4, and 
I1:5, on LM was also affected by anti-CD29 mAb in SFMNC 
from patient 2 (Fig.  3 B). These results indicate that the/31 
integrin-mediated interaction with LM is critically involved 
in the persistent expression of inflammatory cytokine genes. 
We next examined the involvement of TCR/CD3-medi- 
ated recognition of some antigen in the cytokine gene ex- 
pression on LM by adding an anti-CD3 mAb, since a central 
role of T cells, which might react with some antigen in the 
synovium, in perpetuating the inflammatory responses (1), 
and a role of 31 integrins in regulating the TCR/CD3-medi- 
ated T cell activation, have been postulated (13, 14). As indi- 
cated in Fig. 3, B and C, anti-CD3 mAb exhibited an inhibi- 
tory effect similar to that of anti-CD29 mAb. It is interesting 
that not only was the expression of T  cell cytokines, such 
as I1:2 and IL-5, but  also  that of monokines, such as IL-1 
and TNF-ot, greatly affected by anti-CD3 mAb. These results 
suggest a central role of T  cells in regulating the persistent 
expression of inflammatory cytokine genes in SFMNC. 
Discussion 
In the present study, we revealed a critical role of the ~1 
integrin-mediated interaction with ECM proteins in regulating 
865  Miyake  et al.  Brief  Definitive Report Figure 3.  Effect  of anti-CD29, anti-CD3, and anti-CD18 mAb on persistent cytokine gene expression on LM. Cytoplasmic RNA prepared from 
SFMNC (A, patient 1; B, patient 2; and C, patient  3), which were cultured for 16 h in serum-free medium on LM-coated plates in the presence 
or absence of anti-CD29, anti-CD3, or anti-CD18 mAb, was subjected to PCR detection  of the indicated cytokine mRNAs. (ND) Not done. 
the persistent expression  of various  cytokine genes in the 
SFMNC of RA patients in vitro. In addition, a central role 
of T cells in regulating monokine production was also sug- 
gested. These would be responsible for the apparently con- 
stitutive production of various cytokines in vivo in the inflamed 
synovium, where it  is  abundant in ECM  proteins and is 
infiltrated by activated  T  cells with elevated 31 integrins. 
At present, only a little is known about the mechanism 
whereby the 31 integrin-mediated interaction with ECM pro- 
teins regulates cytokine gene expression. It has been reported 
that clustering of 31 integrins led to increased protein tyro- 
sine phosphorylation (20). Yamada et al. (21) reported that 
the VLA-5-mediated interaction with FN  provided a co- 
stimulatory signal requisite for II.-2 gene expression  in pe- 
ripheral blood CD4 + T cells by inducing an AP-1 transcrip- 
tional  factor  independently of  the  TCR/CD3-mediated 
stimulation. AP-1 has been implicated in the transcriptional 
regulation  of  various  cytokines,  including  IL-lo~, IL-13, 
TNF-c~, and II~6 (22). In addition, it has been recently reported 
that 31 integrins on monocytes act as a primary signal trans- 
duction molecule regulating inflammatory cytokine gene ex- 
pression (23). Monocyte adherence also induced the c-fis gene 
expression,  the product of which is a component of AP-1 
(24).  Therefore, it is possible that the AP-1 induction by a 
signal mediated  by 31 integrins may be primarily responsible 
for the ECM induction of various cytokine gene expression 
in SFMNC. 
However,  it seems more likely that the expression of all 
cytokine genes retained on ECM proteins was not necessarily 
directly regulated by the 31 integrin-mediated signal. A com- 
plex cytokine network, such as the TNF induction of mono- 
cyte IL-1 and GM-CSF production (5, 25),  and the IL-1 or 
TNF induction of monocyte IL-8 production (26), has been 
demonstrated to be involved in the inflammatory cytokine 
production in  SFMC.  Alternatively,  contaminated PMN 
would also contribute to the monokine gene expression, since 
they are known to be potent producers of IIA3 and TNF-tx 
(27, 28). Therefore, the high expression of these monokines 
observed in vivo and in vitro might be secondary or tertiary 
in response  to other cytokines in a paracrine  or autocrine 
fashion. The donor-dependent  differences in cytokine produc- 
tion observed in Figs. 1 and 3 might reflect such a complexity 
of the regulatory processes. However, it should be noted that 
anti-CD3 mAb exhibited an inhibitory effect similar to that 
of anti-CD29 mAb on the persistent cytokine gene expres- 
sion on LM. Anti-CD3 mAb inhibited not only the expres- 
sion of T  cell cytokines but also that of monokines. This 
suggests that the monokine production in SFMNC is sec- 
ondary in response to T  cell-derived cytokines or a direct 
contact with activated T cells, as has been represented by the 
IL-1 induction in macrophages through interaction with ac- 
tivated T  cells (29,  30). 
The fact that the persistent cytokine gene expression  in 
SFMNC on LM was blocked by anti-CD3 mAb, as well as 
by anti-CD29 mAb suggests that both the TCR/CD3-medi- 
ated recognition of a certain antigen in the culture and the 
31 integrin-mediated costimulatory signal were required for 
the cytokine gene expression. At present, the antigen involved 
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has been documented in the case of murine qr/6 T cell lines, 
where the "spontaneous" production of Ib4 in response to 
Arg-Gly-Asp (RGD) containing ECM proteins was blocked 
by antivitronectin receptor (/~3 integrin) mAb, as well as by 
anti-CD3  mAb (31).  In that  case,  the "y//i T  cell lines ex- 
pressed a particular combination of V~/and V5 gene prod- 
ucts that has been implicated in the reactivity to a mycobac- 
terial  heat-shock  protein  (hsp)  and  a  self stress  protein, 
suggesting that the TCR-mediated recognition of a self an- 
tigen  was involved in  that  response.  In  this  respect,  it  is 
noteworthy that hsp-reactive T cells have been demonstrated 
to accumulate in the SFMNC of KA patients (9, 10). There- 
fore, it seems likely that bacterial or self hsp might be presented 
by monocytes or activated DR. + T  cells as an antigen  for 
such T cells in the cultures performed in this study. Consis- 
tent with this notion, high proliferative response of a hsp65- 
reactive T cell clone to SFMNC from the inflamed joint (32) 
and an elevated expression of hsp in the RA synovium (10) 
have been demonstrated. In addition, it has been known that 
hsp expression in monocytes could be induced by treatment 
with inflammatory cytokines such as IFN-3' and TNF-ot (33, 
34). Therefore,  hsp-reactive T cells and inflammatory cytokines 
may constitute a circuit perpetuating inflammatory reactions 
in the RA synovium. 
Whatever the antigen is, a costimulatory signal mediated 
by 81 integrins  through  their interaction  with ECM pro- 
teins appear to be requisite for the persistent expression of 
some inflammatory cytokines in RA SFMNC. Therefore, an- 
tibodies or peptides interfering with the integrin-mediated 
interaction with ECM proteins might be useful for quenching 
the overproduction of harmful inflammatory cytokines in the 
affected tissues. Such a possibility is now under investigation 
in experimental  animal  arthritis  systems. 
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